Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy

被引:171
作者
Luis-Rodriguez, Desiree [1 ,2 ]
Martinez-Castelao, Alberto [1 ,3 ]
Gorriz, Jose Luis [1 ,4 ]
de Alvaro, Fernando [1 ,5 ]
Navarro-Gonzalez, Juan F. [1 ,2 ]
机构
[1] GEENDIAB, Madrid, Spain
[2] Univ Hosp Nuestra Senora Candelaria, Nephrol Serv & Res Unit, Santa Cruz, CA 38010 USA
[3] Bellvitge Univ Hosp, Hosp Llobregat, Nephrol Serv, Lhospitalet De Llobregat 08907, Spain
[4] Univ Hosp, Nephrol Serv, Valencia 46017, Spain
[5] Univ Hosp Infanta Sofia, Nephrol Serv, Madrid 28702, Spain
来源
WORLD JOURNAL OF DIABETES | 2012年 / 3卷 / 01期
关键词
Diabetes; Diabetic nephropathy; Innate immunity; Inflammation; Renal failure;
D O I
10.4239/wjd.v3.i1.7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus and its complications are becoming one of the most important health problems in the world. Diabetic nephropathy is now the main cause of end-stage renal disease. The mechanisms leading to the development and progression of renal injury are not well known. Therefore, it is very important to find new pathogenic pathways to provide opportunities for early diagnosis and targets for novel treatments. At the present time, we know that activation of innate immunity with development of a chronic low grade inflammatory response is a recognized factor in the pathogenesis of diabetic nephropathy. Numerous experimental and clinical studies have shown the participation of different inflammatory molecules and pathways in the pathophysiology of this complication. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:7 / 18
页数:12
相关论文
共 136 条
[1]   ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1 [J].
Amann, B ;
Tinzmann, R ;
Angelkort, B .
DIABETES CARE, 2003, 26 (08) :2421-2425
[2]   Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study [J].
Araki, S. ;
Haneda, M. ;
Koya, D. ;
Sugimoto, T. ;
Isshiki, K. ;
Chin-Kanasaki, M. ;
Uzu, T. ;
Kashiwagi, A. .
DIABETOLOGIA, 2007, 50 (04) :867-873
[3]   The epidemiology of chronic kidney disease [J].
Atkins, RC .
KIDNEY INTERNATIONAL, 2005, 67 :S14-S18
[4]  
Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575
[5]   TUMOR NECROSIS FACTOR STIMULATES PROSTAGLANDIN PRODUCTION AND CYCLIC-AMP LEVELS IN RAT CULTURED MESANGIAL CELLS [J].
BAUD, L ;
PEREZ, J ;
FRIEDLANDER, G ;
ARDAILLOU, R .
FEBS LETTERS, 1988, 239 (01) :50-54
[6]  
BAUD L, 1995, MINER ELECTROL METAB, V21, P336
[7]   METABOLIC AND GENETIC-CHARACTERIZATION OF PREDIABETIC STATES - SEQUENCE OF EVENTS LEADING TO NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BECKNIELSEN, H ;
GROOP, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1714-1721
[8]  
BERTANI T, 1989, AM J PATHOL, V134, P419
[9]   Changes of adiponectin oligomer composition by moderate weight reduction [J].
Bobbert, T ;
Rochlitz, H ;
Wegewitz, U ;
Akpulat, S ;
Mai, K ;
Weickert, MO ;
Möhlig, M ;
Pfeiffer, AFH ;
Spranger, J .
DIABETES, 2005, 54 (09) :2712-2719
[10]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610